Vitro Biopharma, Inc. Quarterly Operating Lease, Liability in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Vitro Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2022 to Q2 2024.
Vitro Biopharma, Inc. Operating Lease, Liability for the quarter ending July 31, 2024 was $378K, a 39.2% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$378K	+$106K	+39.2%	Jul 31, 2024	10-Q	2024-09-16
Q1 2024	$410K	+$158K	+62.9%	Apr 30, 2024	10-Q	2024-05-31
Q4 2023	$443K	+$178K	+67.4%	Jan 31, 2024	10-Q	2024-03-14
Q3 2023	$476K			Oct 31, 2023	10-K	2024-01-29
Q2 2023	$271K			May 31, 2023	10-Q	2024-09-16
Q1 2023	$252K			Apr 30, 2023	10-Q	2023-06-13
Q4 2022	$264K			Jan 31, 2023	10-Q	2023-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.